Liver Disease Diagnostics Market, By Technique, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
ÁÖ¿ä ÁøÃâ±â¾÷À¸·Î´Â Boston Scientific Corporation, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc, Abbott, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Horiba Medical, Siemens Healthcare GmbH, PerkinElmer µîÀÌ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå °£Áúȯ Áø´Ü ½ÃÀå °³¿ä
Á¶»ç ¹üÀ§
½ÃÀå ÃßÁ¤ ¿¬µµ
Á¦2Àå ÁÖ¿ä ¿ä¾à
½ÃÀå ³»¿ª
°æÀï ÀλçÀÌÆ®
Á¦3Àå °£Áúȯ Áø´Ü ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ±âȸ
ÇâÈÄ ½ÃÀå µ¿Çâ
Á¦4Àå °£Áúȯ Áø´Ü ¾÷°è Á¶»ç
PEST ºÐ¼®
PorterÀÇ Five Forces ºÐ¼®
¼ºÀå Àü¸Á ¸ÅÇÎ
±ÔÁ¦ ±¸Á¶ ºÐ¼®
Á¦5Àå °£Áúȯ Áø´Ü ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®
COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®
Á¦6Àå °£Áúȯ Áø´Ü ½ÃÀå ±¸µµ
°£Áúȯ Áø´Ü ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
±âÁ¸ ±â¾÷ ºÐ¼®
½Å±Ô ±â¾÷ ºÐ¼®
Á¦7Àå °£Áúȯ Áø´Ü ½ÃÀå - ±â¼úº°
°³¿ä
±â¼úº° ºÎ¹® Á¡À¯À² ºÐ¼®
»ý°Ë
½ÇÇè½Ç °Ë»ç
³»½Ã°æ °Ë»ç
À̹Ì¡
±âŸ
Á¦8Àå °£Áúȯ Áø´Ü ½ÃÀå - ÃÖÁ¾ ¿ëµµº°
°³¿ä
ÃÖÁ¾ ¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
¿¬±¸½Ç
º´¿ø
±âŸ
Á¦9Àå °£Áúȯ Áø´Ü ½ÃÀå - Áö¿ªº°
¼·Ð
ºÏ¹Ì
°³¿ä
ºÏ¹Ì ÁÖ¿ä Á¦Á¶¾÷ü
¹Ì±¹
ij³ª´Ù
À¯·´
°³¿ä
À¯·´ ÁÖ¿ä Á¦Á¶¾÷ü
µ¶ÀÏ
ÀÌÅ»¸®¾Æ
¿µ±¹
ÇÁ¶û½º
·¯½Ã¾Æ
³×´ú¶õµå
½º¿þµ§
Æú¶õµå
±âŸ
¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
°³¿ä
¾Æ½Ã¾ÆÅÂÆò¾ç ÁÖ¿ä Á¦Á¶¾÷ü
Àεµ
Áß±¹
ÀϺ»
Çѱ¹
È£ÁÖ
ű¹
Àεµ³×½Ã¾Æ
Çʸ®ÇÉ
±âŸ
¶óƾ¾Æ¸Þ¸®Ä«
°³¿ä
¶óƾ¾Æ¸Þ¸®Ä« ÁÖ¿ä Á¦Á¶¾÷ü
ºê¶óÁú
¸ß½ÃÄÚ
¾Æ¸£ÇîÆ¼³ª
ÄÝ·Òºñ¾Æ
±âŸ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°³¿ä
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÁÖ¿ä Á¦Á¶¾÷ü
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
À̽º¶ó¿¤
ÅÍŰ
¾ËÁ¦¸®
ÀÌÁýÆ®
±âŸ
Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® - °£Áúȯ Áø´Ü ¾÷°è
°æÀï ´ë½Ãº¸µå
±â¾÷ °³¿ä
Boston Scientific Corporation
Laboratory Corporation of America Holdings
Thermo Fisher Scientific Inc.
Randox Laboratories Ltd.
Abbott
F. Hoffmann-La Roche Ltd.
Fujifilm Corporation
Horiba Medical
Siemens Healthcare GmbH
PerkinElmer
Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á
LSH
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
REPORT HIGHLIGHT
Liver Disease Diagnostics Market size was valued at USD 37,669 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.
Any ailment that affects the liver is referred to as "liver disease" in general. Although the causes of these disorders vary, they can all harm the liver and impair its ability to operate. Liver disorders include hepatitis, alcoholic fatty liver disease, primary biliary cirrhosis (PBC), primary sclerosing cholangitis, Wilson's disease, liver cirrhosis, and jaundice can all be diagnosed with the use of liver disease tests. Different procedures, including imaging, laboratory testing, endoscopy, and biopsy, can be used to identify liver disorders.
Liver Disease Diagnostics Market- Market Dynamics
Rising prevalence of chronic liver disease drive market growth
One of the main reasons anticipated to propel the liver disease diagnostics market is the increasing frequency of both acute and chronic liver illnesses. For instance, the WHO estimates that 830,000 deaths worldwide in 2020 were attributable to liver cancer. Furthermore, one of the main causes of death and morbidity is chronic liver disease (CLD), which affects approximately 1.5 billion people globally, according to a study paper titled "Global Epidemiology of Chronic Liver Disease" that was published in June 2021. Thus, the aforementioned stats drive the market growth.
Liver Disease Diagnostics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)
Based on technique segmentation, the imaging segment is expected to hold a prominent market share over the forecast period
Based on end-use segmentation, the Hospitals segment is expected to hold the largest market share during the forecast period
Based on region, North America held the largest market share in 2023
The Global Liver Disease Diagnostics Market is segmented based on Technique, End-use and Region.
Based on the technique, the Liver Disease Diagnostics market is bifurcated into Biopsy, Laboratory tests, Endoscopy, Imaging and Others. The Imaging segment is expected to hold a prominent market share over the forecast period. This is explained by the increasing number of efforts made to create cutting-edge imaging techniques by major companies in the liver disease diagnostics market. Liver function is diagnosed in lab settings utilizing urine, blood, and other fluid samples. However, imaging comprises several tests such as CT, MRI, X-ray, ultrasound, and magnetic resonance imaging (MRI).
Based on the end-use, the global Liver Disease Diagnostics market is segmented into Laboratories, Hospitals and Others. The Hospitals segment is expected to hold the largest market share during the forecast period because most patients depend on hospitals that are well-stocked with diagnostic testing equipment. The market for liver disease diagnostics is expanding because hospitals give patients the best treatment possible and facilitate early identification and diagnosis. It is also expected that the continuous infrastructure development in healthcare would improve the current hospital facilities.
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share during the forecast period. The presence of major players and significant R&D expenditures are two factors that are anticipated to fuel the growth of the liver disease diagnostics market in the area. Moreover, the existence of institutions that furnish individuals with information concerning medical diagnosis is anticipated to stimulate the expansion of the liver disease diagnostics market. One such website is GetPalliativeCare.org, which offers information on palliative care about diagnostic procedures including CT scans, endoscopies, and biopsies. For instance, the most common liver condition in 2020 was non-alcoholic fatty liver disease, affecting over 7 million individuals. According to the Canadian Liver Foundation's 2021 report, liver cancer is the most deadly and rapidly growing kind of cancer in Canada.
The key players operating in the market are Boston Scientific Corporation, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Abbott, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Horiba Medical, Siemens Healthcare GmbH and PerkinElmer.
Recent Developments:
In October 2023, an AI-assisted laboratory-designed test (LDT) for the histologic scoring and staging of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) was introduced by PathAI Diagnostics, a top provider of laboratory services.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LIVER DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Boston Scientific Corporation
Laboratory Corporation of America Holdings
Thermo Fisher Scientific Inc.
Randox Laboratories Ltd.
Abbott
F. Hoffmann-La Roche Ltd.
Fujifilm Corporation
Horiba Medical
Siemens Healthcare GmbH
PerkinElmer
GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032
Biopsy
Laboratory tests
Endoscopy
Imaging
Others
GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
Laboratories
Hospitals
Others
GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1.Liver Disease Diagnostics Market Overview
1.1.Study Scope
1.2.Market Estimation Years
2.Executive Summary
2.1.Market Snippet
2.1.1.Liver Disease Diagnostics Market Snippet by Technique
2.1.2.Liver Disease Diagnostics Market Snippet by End-use
2.1.3.Liver Disease Diagnostics Market Snippet by Country
2.1.4.Liver Disease Diagnostics Market Snippet by Region